Burstein, H. J. (2024). I mmunotherapy for Early-Stage Triple-Negative Breast Cancer. New England Journal of Medicine, 391(21), 2048. https://doi.org/10.1056/NEJMe24116O6
Chicago Style (17th ed.) CitationBurstein, Harold J. "I Mmunotherapy for Early-Stage Triple-Negative Breast Cancer." New England Journal of Medicine 391, no. 21 (2024): 2048. https://doi.org/10.1056/NEJMe24116O6.
MLA (9th ed.) CitationBurstein, Harold J. "I Mmunotherapy for Early-Stage Triple-Negative Breast Cancer." New England Journal of Medicine, vol. 391, no. 21, 2024, p. 2048, https://doi.org/10.1056/NEJMe24116O6.
Warning: These citations may not always be 100% accurate.